Sandoz Pharmaceuticals Corp. v. Blinn Wholesale Drug Co. (In Re Blinn Wholesale Drug Co.)

164 B.R. 440, 25 U.C.C. Rep. Serv. 2d (West) 103, 1994 Bankr. LEXIS 887, 1994 WL 58276
CourtUnited States Bankruptcy Court, E.D. New York
DecidedFebruary 22, 1994
Docket8-16-71159
StatusPublished
Cited by7 cases

This text of 164 B.R. 440 (Sandoz Pharmaceuticals Corp. v. Blinn Wholesale Drug Co. (In Re Blinn Wholesale Drug Co.)) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sandoz Pharmaceuticals Corp. v. Blinn Wholesale Drug Co. (In Re Blinn Wholesale Drug Co.), 164 B.R. 440, 25 U.C.C. Rep. Serv. 2d (West) 103, 1994 Bankr. LEXIS 887, 1994 WL 58276 (N.Y. 1994).

Opinion

DECISION, ORDER AND JUDGMENT DETERMINING RIGHTS BETWEEN RECLAIMING SELLER AND LIEN CREDITOR

ROBERT JOHN HALL, Bankruptcy Judge.

PRELIMINARY STATEMENT

This matter comes before the Court upon a motion for summary judgment (“Motion”) by plaintiff Sandoz Pharmaceuticals Corporation (“Plaintiff’), and a cross-motion (“Cross-motion”) by the debtor, Blinn Wholesale Drug Co., Inc. (“Debtor”) for summary judgment dismissing Plaintiffs adversary proceeding (“Adversary Proceeding”). The Adversary Proceeding was commenced by Plaintiff, a seller of goods, seeking an order declaring the validity of, and compelling Debtor’s compliance with, Plaintiffs alleged right to reclaim, pursuant to New York’s Uniform Commercial Code, goods fully encumbered by a lien held by Congress Financial Corp. (“Congress”).

The Court has jurisdiction over this case pursuant to section 157(a), 157(b)(1) and 1334(a) of title 28, United States Code (“title 28”) and the order of referral of matters to the bankruptcy judges by the United States District Court for the Eastern District New York (Weinstein, C.J., 1986). This is a core proceeding pursuant to section 157(b)(2)(A), (B), (K), and (0) of title 28.

For the reasons set forth below, the Court holds that: (1) Plaintiff holds a VALID right *442 of reclamation, the subject of which is the pharmaceutics it delivered to Debtor on credit; (2) this reclamation right is SUBJECT to Congress’s security interest as a good faith purchaser for value; (3) Plaintiffs right of reclamation was denied when the pharmaceutics were sold; (4) this right of reclamation was the right to reclaim goods fully encumbered by liens and the right was valueless; (5) Plaintiffs resulting secured or administrative expense priority claim must accordingly be valueless; (6) Debtor is authorized and DIRECTED to tender to Congress an amount sufficient to satisfy its claims against the estate, such tender not to exceed the value of the property remaining in the estate, and such tender to be made so as to be actually received by Congress on or before March 31, 1994; (7) all other requests for relief by Plaintiff are DENIED; (8) Congress is directed to furnish an ACCOUNTING of the amount and extent of the satisfaction and release, if any, of its lien, to the Court, Debtor and Plaintiff, so as to be actually filed and received on or before April 22, 1994; and (9) Debtor’s Cross-motion for summary judgment is GRANTED and Plaintiffs Adversary Proceeding is DISMISSED and to be CLOSED by the Clerk’s Office.

UNCONTESTED FACTS

On December 17, 1991 (“Petition Date”), Debtor filed a petition for relief under chapter 11 of title 11, United States Code (“Bankruptcy Code” or “Code”). The following events occurred prior to the Petition Date.

On March 30,1990, Debtor obtained a loan from Congress. 1 Pursuant to their financing agreement, Congress received a lien upon all of Debtor’s present and after-acquired inventory and all other personal property (“Collateral”).

On December 4, 1991, and again on December 10, 1991, Plaintiff sold certain pharmaceutical goods to Debtor on credit. The price due for all goods delivered was $51,-086.85. All pharmaceutics were received by Debtor within ten days prior to the Petition Date; some were sold by Debtor pre-petition.

As of the Petition Date, the amount owed by Debtor to Congress exceeded $17,000,-000.00, which was in excess of the value of the Collateral. Debtor subsequently obtained Court authorization for up to $20,000,-000.00 of continued financing by Congress. Order Authorizing Permanent Financing, dated February 20, 1992. Congress’s advances were again to be secured by virtually all personal property of Debtor, that is, the Collateral.

On the Petition Date, Debtor received from Plaintiff a written demand seeking reclamation of the goods sold on December 4th and 10th, 1991, pursuant to section 2-702 of New York’s Uniform Commercial Code (“NYUCC”). 2 While, as stated above, some of the pharmaceutical goods had already been sold prior to Plaintiffs reclamation demand, $37,876.85 worth of the goods remained in Debtor’s possession. Insisting that all pharmaceutics delivered by Plaintiff formed part of the Collateral encumbered by Congress’s “blanket” lien, Debtor refused to comply with Plaintiffs reclamation demand.

By order dated June 11, 1992, the Court approved the sale of all or substantially all of Debtor’s assets to Commons Metro, Inc. (“Sale Order”). The amount received by Debtor’s estate was substantially less than the claim of Congress. Pursuant to the Sale Order, Plaintiffs reclamation right, if any, continued in the proceeds of the sale of the Collateral (“Proceeds”). Order Pursuant to 11 U.S.C. § 363, dated June 11, 1992, at 5-6.

On November 19, 1992, Plaintiff filed the Motion seeking summary judgment determining (1) that its reclamation demand is valid and, among other things, (2) “requiring [Debtor] to pay said reclamation claim”. Plaintiffs Motion, dated November 18, 1992, at 1. On December 8, 1992, Debtor filed the *443 Cross-motion, which opposed Plaintiffs Motion and sought summary judgment dismissing the Adversary Proceeding. After oral argument was heard on the Motion and Cross-motion, the Court reserved decision.

The issues are: (1) the validity of Plaintiffs reclamation demand in light of Congress’s prior perfected lien upon the same goods (Proceeds), and (2) if Plaintiff holds a valid right of reclamation, how that right should be treated, again, in light of Congress’s superior lien.

LEGAL DISCUSSION

A. Seller’s State Law Reclamation Right

In New York, a seller’s right to reclamation is established by section 2-702 of the NYUCC (“section 2-702”). N.Y.U.C.C. § 2-702 (McKinney 1993). Subsections (2) and (3) of section 2-702 state in pertinent part:

(2) Where the seller discovers that the buyer has received goods on credit while insolvent he may reclaim the goods upon demand made within ten days after the receipt....
(3) The seller’s right to reclaim under subsection (2) is subject to the rights of a buyer in ordinary course or other good faith purchaser under this Article....

N.Y.U.C.C. § 2—702(2)—(3) (McKinney 1993).

Section 2-702(2) is satisfied by the undisputed facts of the case at bar: Plaintiff, a seller, delivered goods on credit to Debtor, an insolvent buyer, and demanded in writing reclamation of the goods before ten days after Debtor received the goods. Accordingly, the Court holds that Plaintiff has a statutory right of reclamation under New York state law. Id. § 2-702(2) (McKinney 1993).

A seller’s reclamation rights can be diminished, however, by section 2-702(3) which provides that the seller’s reclamation right is “subject to the rights of a buyer in ordinary course or other good faith purchaser”. Id. § 2-702(3) (McKinney 1993). Debtor maintains that Congress is a good faith purchaser for value with rights in the Proceeds which are superior to Plaintiffs right of reclamation.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
164 B.R. 440, 25 U.C.C. Rep. Serv. 2d (West) 103, 1994 Bankr. LEXIS 887, 1994 WL 58276, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sandoz-pharmaceuticals-corp-v-blinn-wholesale-drug-co-in-re-blinn-nyeb-1994.